Treatment of lower-risk myelodysplastic syndromes
Myelodysplastic neoplasms (MDS) involve clonal hematopoiesis and cellular dysplasia, driven by genetic and epigenetic alterations. Spliceosome mutations and epigenetic dysregulation underscore the intricate pathogenesis of MDS. The bone marrow microenvironment, stromal dysfunction, chronic inflamma...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ferrata Storti Foundation
2024-10-01
|
| Col·lecció: | Haematologica |
| Accés en línia: | https://haematologica.org/article/view/11799 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|